Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis - PubMed (original) (raw)
. 1993 Apr 15;53(8):1719-23.
Affiliations
- PMID: 8467484
Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis
H Murakami et al. Cancer Res. 1993.
Abstract
Double transgenic mice bearing fusion genes consisting of mouse albumin enhancer/promoter-mouse c-myc complementary DNA and mouse metallothionein 1 promoter-human transforming growth factor alpha complementary DNA were generated to investigate the interaction of these genes in hepatic oncogenesis and to provide a general paradigm for characterizing the interaction of nuclear oncogenes and growth factors in tumorigenesis. Coexpression of c-myc and transforming growth factor alpha as transgenes in the mouse liver resulted in a tremendous acceleration of neoplastic development in this organ as compared to expression of either of these transgenes alone. The two distinct cellular reactions that occurred in the liver of the double transgenic mice prior to the appearance of liver tumors were dysplastic and apoptotic changes in the existing hepatocytes followed by emergence of multiple focal lesions composed of both hyperplastic and dysplastic cell populations. These observations suggest that the interaction of c-myc and transforming growth factor alpha, and possibly other combinations of nuclear oncogenes and growth factors, during development of hepatic neoplasia contributes to the selection and expansion of the preneoplastic cell populations which consequently increases the probability of malignant conversion.
Similar articles
- Transgenic mouse models in carcinogenesis: interaction of c-myc with transforming growth factor alpha and hepatocyte growth factor in hepatocarcinogenesis.
Thorgeirsson SS, Santoni-Rugiu E. Thorgeirsson SS, et al. Br J Clin Pharmacol. 1996 Jul;42(1):43-52. doi: 10.1046/j.1365-2125.1996.03748.x. Br J Clin Pharmacol. 1996. PMID: 8807143 Free PMC article. - Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha.
Santoni-Rugiu E, Nagy P, Jensen MR, Factor VM, Thorgeirsson SS. Santoni-Rugiu E, et al. Am J Pathol. 1996 Aug;149(2):407-28. Am J Pathol. 1996. PMID: 8701981 Free PMC article. - Interaction of c-myc with transforming growth factor alpha and hepatocyte growth factor in hepatocarcinogenesis.
Thorgeirsson SS, Santoni-Rugiu E. Thorgeirsson SS, et al. Mutat Res. 1997 May 12;376(1-2):221-34. doi: 10.1016/s0027-5107(97)00047-x. Mutat Res. 1997. PMID: 9202759 - Molecular mechanisms of hepatocarcinogenesis in transgenic mouse models of liver cancer.
Calvisi DF, Thorgeirsson SS. Calvisi DF, et al. Toxicol Pathol. 2005;33(1):181-4. doi: 10.1080/01926230590522095. Toxicol Pathol. 2005. PMID: 15805070 Review. - TGF beta regulation of cell proliferation.
Moses HL, Arteaga CL, Alexandrow MG, Dagnino L, Kawabata M, Pierce DF Jr, Serra R. Moses HL, et al. Princess Takamatsu Symp. 1994;24:250-63. Princess Takamatsu Symp. 1994. PMID: 8983080 Review.
Cited by
- Preclinical Models of Hepatocellular Carcinoma: Current Utility, Limitations, and Challenges.
Cigliano A, Liao W, Deiana GA, Rizzo D, Chen X, Calvisi DF. Cigliano A, et al. Biomedicines. 2024 Jul 22;12(7):1624. doi: 10.3390/biomedicines12071624. Biomedicines. 2024. PMID: 39062197 Free PMC article. Review. - New and Old Key Players in Liver Cancer.
Cuesta ÁM, Palao N, Bragado P, Gutierrez-Uzquiza A, Herrera B, Sánchez A, Porras A. Cuesta ÁM, et al. Int J Mol Sci. 2023 Dec 5;24(24):17152. doi: 10.3390/ijms242417152. Int J Mol Sci. 2023. PMID: 38138981 Free PMC article. Review. - Assessment of the Pharmacokinetics, Disposition, and Duration of Action of the Tumour-Targeting Peptide CEND-1.
Järveläinen HA, Schmithals C, von Harten M, Kakoschky B, Vogl TJ, Harris S, Henson C, Bullen-Clerkson G, Piiper A. Järveläinen HA, et al. Int J Mol Sci. 2023 Mar 16;24(6):5700. doi: 10.3390/ijms24065700. Int J Mol Sci. 2023. PMID: 36982773 Free PMC article. - WD repeat domain 48 promotes hepatocellular carcinoma progression by stabilizing c-Myc.
Li B, Zhang YW, Cao K, Li C, Chen Q, Jiang YH, Luo LL, Zuo S. Li B, et al. J Cell Mol Med. 2022 Dec;26(23):5755-5766. doi: 10.1111/jcmm.17583. Epub 2022 Nov 20. J Cell Mol Med. 2022. PMID: 36403194 Free PMC article. - Mouse Models of Hepatocellular Carcinoma: Classification, Advancement, and Application.
Liu S, Huang F, Ru G, Wang Y, Zhang B, Chen X, Chu L. Liu S, et al. Front Oncol. 2022 Jun 30;12:902820. doi: 10.3389/fonc.2022.902820. eCollection 2022. Front Oncol. 2022. PMID: 35847898 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases